NO20052535D0 - Polynucleotide. - Google Patents

Polynucleotide.

Info

Publication number
NO20052535D0
NO20052535D0 NO20052535A NO20052535A NO20052535D0 NO 20052535 D0 NO20052535 D0 NO 20052535D0 NO 20052535 A NO20052535 A NO 20052535A NO 20052535 A NO20052535 A NO 20052535A NO 20052535 D0 NO20052535 D0 NO 20052535D0
Authority
NO
Norway
Prior art keywords
polynucleotide
Prior art date
Application number
NO20052535A
Other languages
English (en)
Other versions
NO323175B1 (no
Inventor
Jan O Aasly
Matthew J Farrer
Zbigniew K Wszolek
Original Assignee
Zbigniew K Wszolek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20045612A external-priority patent/NO20045612D0/no
Application filed by Zbigniew K Wszolek filed Critical Zbigniew K Wszolek
Priority to NO20052535A priority Critical patent/NO323175B1/no
Publication of NO20052535D0 publication Critical patent/NO20052535D0/no
Priority to AU2005319787A priority patent/AU2005319787B2/en
Priority to CA002606672A priority patent/CA2606672A1/en
Priority to US10/568,414 priority patent/US7544786B2/en
Priority to EP05823159A priority patent/EP1838871A1/en
Priority to PCT/NO2005/000465 priority patent/WO2006068492A1/en
Publication of NO323175B1 publication Critical patent/NO323175B1/no
Priority to US12/433,385 priority patent/US7993841B2/en
Priority to US13/172,412 priority patent/US8455243B2/en
Priority to US13/875,048 priority patent/US20130219536A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20052535A 2004-12-23 2005-05-27 Framgangsmate for a pavise en mutasjon som forarsaker arvelig parkinsonisme NO323175B1 (no)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NO20052535A NO323175B1 (no) 2004-12-23 2005-05-27 Framgangsmate for a pavise en mutasjon som forarsaker arvelig parkinsonisme
PCT/NO2005/000465 WO2006068492A1 (en) 2004-12-23 2005-12-19 A novel polynucleotide involved in heritable parkinson's disease
EP05823159A EP1838871A1 (en) 2004-12-23 2005-12-19 A novel polynucleotide involved in heritable parkinson's disease
US10/568,414 US7544786B2 (en) 2004-12-23 2005-12-19 Polynucleotide
CA002606672A CA2606672A1 (en) 2004-12-23 2005-12-19 A novel polynucleotide involved in heritable parkinson's disease
AU2005319787A AU2005319787B2 (en) 2004-12-23 2005-12-19 A novel polynucleotide involved in heritable Parkinson's disease
US12/433,385 US7993841B2 (en) 2004-12-23 2009-04-30 Method of screening for LRRK2-related parkinsonism inheritance
US13/172,412 US8455243B2 (en) 2004-12-23 2011-06-29 LRRK2 polynucleotides
US13/875,048 US20130219536A1 (en) 2004-12-23 2013-05-01 Lrrk2 polynucleotides and trangenic animals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20045612A NO20045612D0 (no) 2004-12-23 2004-12-23 Polynukleotid
NO20052535A NO323175B1 (no) 2004-12-23 2005-05-27 Framgangsmate for a pavise en mutasjon som forarsaker arvelig parkinsonisme

Publications (2)

Publication Number Publication Date
NO20052535D0 true NO20052535D0 (no) 2005-05-27
NO323175B1 NO323175B1 (no) 2007-01-15

Family

ID=35276962

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052535A NO323175B1 (no) 2004-12-23 2005-05-27 Framgangsmate for a pavise en mutasjon som forarsaker arvelig parkinsonisme

Country Status (6)

Country Link
US (4) US7544786B2 (no)
EP (1) EP1838871A1 (no)
AU (1) AU2005319787B2 (no)
CA (1) CA2606672A1 (no)
NO (1) NO323175B1 (no)
WO (1) WO2006068492A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO323175B1 (no) 2004-12-23 2007-01-15 Jan O Aasly Framgangsmate for a pavise en mutasjon som forarsaker arvelig parkinsonisme
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
EP2601609B1 (en) 2010-08-02 2017-05-17 Population Bio, Inc. Compositions and methods for discovery of causative mutations in genetic disorders
US9365551B2 (en) 2010-09-02 2016-06-14 Glaxo Group Limited 2-(benzyloxy) benzamides as LRRK2 kinase inhibitors
PL2760453T3 (pl) 2011-09-30 2016-11-30 Makrocykliczne Inhibitory kinazy LRRK2
US10221454B2 (en) 2011-10-10 2019-03-05 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
US11180807B2 (en) * 2011-11-04 2021-11-23 Population Bio, Inc. Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
CA2863887C (en) 2012-02-09 2023-01-03 Population Diagnostics, Inc. Methods of screening low frequency gdna variation biomarkers for pervasive developmental disorder (pdd) or pervasive developmental disorder - not otherwise specified (pdd_nos)
EP2895621B1 (en) 2012-09-14 2020-10-21 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
EP2900835A4 (en) 2012-09-27 2016-05-11 Population Diagnotics Inc METHODS AND COMPOSITIONS FOR DETECTING AND TREATING DEVELOPMENTAL DISORDERS
US10087186B2 (en) 2014-01-29 2018-10-02 Glaxosmithkline Intellectual Property Development Limited Compounds as LRRK2 kinase inhibitors
US10724096B2 (en) 2014-09-05 2020-07-28 Population Bio, Inc. Methods and compositions for inhibiting and treating neurological conditions
WO2016042089A1 (en) 2014-09-17 2016-03-24 Oncodesign S.A. Macrocyclic lrrk2 kinase inhibitors
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
BR112020000772A2 (pt) 2017-07-14 2020-07-21 Glaxosmithkline Intellectual Property Development Limited inibidores de cinase 2 de repetição rica em leucina
SI3625368T1 (sl) 2018-08-08 2023-04-28 Pml Screening, Llc Postopki z genetskim testiranjem za oceno tveganja za razvoj progresivne multifokalne levkoencefalopatije, ki jo povzroča virus John Cunningham

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420547B1 (en) * 1999-06-03 2002-07-16 University Of Kentucky Research Foundation Use of the full length transcript (FLt) from mirabilis mosaic caulimovirus to express chimeric genes in plants
CA2443378A1 (en) * 2001-04-04 2002-10-17 Allergan, Inc. Methods of screening and using inhibitors of angiogenesis
AU2005299089B2 (en) 2004-10-21 2011-08-18 Eberhard Karls Universitaet Tuebingen KASPP (LRKK2) gene, its production and use for the detection and treatment of neurodegenerative disorders
NO323175B1 (no) 2004-12-23 2007-01-15 Jan O Aasly Framgangsmate for a pavise en mutasjon som forarsaker arvelig parkinsonisme

Also Published As

Publication number Publication date
AU2005319787B2 (en) 2011-12-01
US7993841B2 (en) 2011-08-09
WO2006068492A1 (en) 2006-06-29
US20080009454A1 (en) 2008-01-10
CA2606672A1 (en) 2006-06-29
AU2005319787A1 (en) 2006-06-29
EP1838871A1 (en) 2007-10-03
US20100003685A1 (en) 2010-01-07
US20130219536A1 (en) 2013-08-22
US8455243B2 (en) 2013-06-04
NO323175B1 (no) 2007-01-15
US20120030781A1 (en) 2012-02-02
US7544786B2 (en) 2009-06-09

Similar Documents

Publication Publication Date Title
NL300935I2 (nl) guselkumab.
NO20052535D0 (no) Polynucleotide.
NL1028967A1 (nl) 4-Fenylamino-chinazoline-6-yl-amiden.
NO20051522D0 (no) Kabelskjotbeskytter.
NO20053210D0 (no) Linneslakkompensator.
NO20053161D0 (no) Mikrobedrepende sammensetning.
NO20051199D0 (no) Rorhandteringsutstyr.
NL1030713A1 (nl) Macroliden.
NO20052746D0 (no) Avlopsenhet.
NO20053362D0 (no) Syklofuge.
NO20041374D0 (no) Bolgekraftverk.
NO20052482D0 (no) Redningskokong.
NO20040762D0 (no) Stromskinne.
NL1028622A1 (nl) Stelwig.
ES1057865Y (es) Desatascador de desagues.
NL1025196A1 (nl) Hark-Zeef-Vork.
NO20045612D0 (no) Polynukleotid
ES1059191Y (es) Candelero tritubular.
ES1059938Y (es) Paleta batefuegos escalonada.
ES1057922Y (es) Vitrina frigorifica polivalente.
ES1057217Y (es) Canape elevable.
ES1057779Y (es) Tenso-papelera.
ES1058195Y (es) Expositor -botellero.
ES1058279Y (es) Cantonera.
NO20041511D0 (no) Energiomvandlingssystem.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees